C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 211/46 (2006.01) A61K 31/4468 (2006.01) A61K 31/45 (2006.01) C07D 211/36 (2006.01)
Patent
CA 2565953
The invention relates to compounds according to formula I exhibiting neurokinin inhibitory properties, a pharmaceutical composition comprising, same and a method of treatment for neurokinin-mediated conditions. Formula (I) or a pharmaceutically acceptable salt or solvate thereof wherein: m,=0 or 1; n =0 or 1; s=0 or 1; L is -O- or -N(R4 )-; R1 and R2 are each independently H, aryl, heteroaryl, -(C1-C6)atkylheterocyloalkyl, -(C1-C6)alkylheterocycloalkyl, -(C1-C6)alkylheteroaryl, -(C1-C6)alkyl-O-aryl, -(C1- C6)alkylaryl, and -CH2 N(R4)(R5), wherein each of said heterocyloalkyl, -(C1- C6)alkylheterocycloalkyl, -(C1-C6)alkylheteroaryl, -(C1-C6)alkyl-0-aryl, aryl, -(C1-C6)alkylaryl, heteroaryl, and -CH2N(R4)(R5), is optionally substituted with 1-3 moieties independently selected from X', Y' or Z'; R3 is H, CF3, OH, or-(C1-C6)alkyl; R4, and R5, are each independently selected from H, -(C1- C6)alkyl, or -(C1-C6)(C=0)R7; R7 is (C1-C6)alkyl, OH, -N(R4)(R), or -OR4; R8 and R9 are each independently (C1-C6)alkyl; X, Y, X', Y' and Z' are each independently selected from H, -(C1-C6)alkyl, -(C1-C6)alkyl-NR 4R5, CF3, OH, - O-(C1-C6)alkyl, -(C1-C6)alkyl-C(=0)R7, aryl, heteroaryl, cycloalkyl, -N02, - (C1-C6)alkylaryl, -0-aryl, halogen, CN, -CH3N(R4)(R5), -C(=O)R7, -C(=O)R7, - R6C(=0)R7 or -R6C(=O)NR4R5; and R6 is a bond, -CH2-, -0-, or -NR4~.
La présente invention concerne des composés de formule (I), ou un sel ou solvate de ceux-ci, acceptable d'un point de vue pharmaceutique, ayant des propriétés d'inhibition de la neurokinine, une composition pharmaceutique les comprenant, et un procédé pour traiter des états pathologiques liés à la neurokinine. Dans la formule (I): m=0 ou 1; n =0 ou 1; s=0 ou 1; L est -O- ou -N(R?4¿ )-; R?1¿ et R?2¿ sont chacun indépendamment H, aryle, hétéroaryle, (C?1¿-C?6¿)alkyle, hétérocycloalkyle, (C¿1?-C¿6?) alkylhétérocycloalkyle, (C¿1-?C¿6?)alkylhétéroaryle, (C¿1-?C¿6?)alkyl-O-aryle, (C¿1- ?C¿6?)alkylaryle, et -CH¿2 ?N(R?4¿)(R?5¿), chacun des éléments hétérocycloalkyle, (C¿1?-C¿6?) alkylhétérocycloalkyle, (C¿1-?C¿6?)alkylhétéroaryle, (C¿1-?C¿6?)alkyl-O-aryle, (C¿1- ?C¿6?)alkylaryle, hétéroaryle et -CH¿2 ?N(R?4¿)(R?5¿) étant éventuellement substitué avec 1-3 fractions choisies indépendamment entre X', Y' ou Z'; R?3¿ est H, CF¿3?, OH, ou-(C¿1-?C¿6?)alkyle; R?4¿ et R?5¿ sont chacun indépendamment choisis entre H, -(C¿1-?C¿6?)alkyle, ou -(C¿1-?C¿6?)(C=O)R?7¿; R?7¿ est (C¿1-?C¿6?)alkyle, OH, -N(R?4¿)(R?5¿), ou -OR?4¿; R?8¿ et R?9¿ sont chacun indépendamment (C¿1-?C¿6?)alkyle; X, Y, X', Y' et Z' sont chacun choisis indépendamment entre H, -(C¿1-?C¿6?)alkyle, -(C¿1-?C¿6?)alkyl-NR?4¿R?5¿,? ¿CF¿3?, OH, -O-(C¿1-?C¿6?)alkyle, -(C¿1-?C¿6?)alkyl-C(=O)R?7¿, aryle, hétéroaryle, cycloalkyle, -NO¿2?, -(C¿1-?C¿6?)alkylaryle, -O-aryle, halogène, CN, -CH¿3?N(R?4¿)(R?5¿), -C(=O)R?7¿, -C(=O)R?7¿, -R?6¿C(=O)R?7¿ ou -R?6¿C(=O)NR?4¿R?5¿; et R?6¿ est une liaison, -CH¿2?-, -O-, ou -NR?4¿-.
O'neill Brian Thomas
Parikh Vinod Dipak
Welch Willard Mckowan Jr.
Pfizer Products Inc.
Sim & Mcburney
LandOfFree
Piperidine derivatives as nk1 and nk3 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperidine derivatives as nk1 and nk3 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine derivatives as nk1 and nk3 antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1485816